Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thomas C Shank"'
Autor:
Kiran Gupta, Jeffrey Trocio, Allison Keshishian, Qisu Zhang, Oluwaseyi Dina, Jack Mardekian, Anagha Nadkarni, Thomas C Shank
Publikováno v:
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but
Externí odkaz:
https://doaj.org/article/0e59f113745d43bf897ef028f78cd1f3
Autor:
Qisu Zhang, Thomas C. Shank, Kiran Gupta, Jack Mardekian, Anagha Nadkarni, Oluwaseyi Dina, Jeffrey Trocio, Allison Keshishian
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-10 (2019)
Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but the comp
Autor:
Renee A. Bellanger, Thomas C. Shank
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 50(3)
Objective To assess the knowledge and attitudes of Texas pharmacists regarding continuing professional development (CPD). Design Descriptive, nonexperimental cross-sectional study. Setting Texas during 2008. Participants 4,954 pharmacists were contac